Canyu Lei

Canyu Lei, Fenglin Zhang, Derek Bivona et al.

Myocardial substrate abnormalities, such as myocardial scar and myocardial infarction (MI), are associated with adverse cardiovascular outcomes. Electrocardiography (ECG) provides a low-cost and widely available tool for detecting these abnormalities, but ECG-based detection remains challenging due to heterogeneous lead-dependent manifestations, high-dimensional multi-lead signals, class imbalance, and the limited interpretability of deep learning models. We propose a multi-scale attention-enhanced convolutional network (MSAIC-Net) for ECG-based myocardial substrate abnormality detection. MSAIC-Net employs parallel atrous convolutional branches to extract ECG features across multiple temporal receptive fields. %, enabling the model to capture both local and longer-range temporal patterns. Channel attention is then used to adaptively reweight informative lead-wise and feature-channel representations. To address class imbalance and improve feature separability, we introduce a novel imbalance-aware supervised contrastive learning strategy that encourages samples from the same class to form compact representations while increasing separation between abnormal and normal samples. Lead-wise permutation importance is further incorporated to quantify the contribution of each ECG lead and improve model interpretability. The proposed method was evaluated on two complementary datasets: a low-data institutional cohort from the University of Virginia (UVA) Health System for myocardial scar classification and the large-scale public PTB-XL dataset from PhysioNet for MI identification. Experimental results show that MSAIC-Net outperforms baseline models, with particularly pronounced improvements in the low-data UVA cohort. Overall, the proposed framework provides an effective and interpretable approach for ECG-based detection of myocardial substrate abnormalities.

Canyu Lei, David Repaske, Jianxin Xie

Effective diabetes management requires continuous monitoring of glycemic levels. Clinically, glycemic control is assessed using metrics such as Time in Range (TIR), Time Below Range (TBR), and Time Above Range (TAR), typically derived from continuous glucose monitoring (CGM). However, many patients rely on self-monitoring of blood glucose (SMBG) due to the high cost and limited accessibility of CGM. Unlike CGM, SMBG provides sparse and irregular measurements, making accurate estimation of these metrics challenging. Conventional supervised learning approaches struggle under such sparsity, leading to poor generalization and unstable performance. To address this, we propose PACD-Net, a self-supervised contrastive knowledge distillation framework for estimating glycemic control from SMBG. Pseudo-SMBG samples with richer temporal coverage are used as teacher signals to guide learning from sparse observations. In addition, multi-view contrastive learning enforces representation consistency across diverse sampling patterns. The model adopts a hybrid Swin Transformer-CNN backbone to capture temporal dependencies in sparse SMBG sequences. Experimental results demonstrate that PACD-Net consistently outperforms existing methods in estimating TAR, TIR, and TBR from real-world SMBG data, achieving improved accuracy as well as enhanced stability and generalization under extremely sparse observation settings. The proposed framework provides a practical tool for clinical SMBG interpretation and offers a generalizable approach for learning from sparse and irregularly sampled sensor data in broader applications.

Canyu Lei, Benjamin Lobo, Jianxin Xie

Continuous glucose monitoring (CGM) provides dense and dynamic glucose profiles that enable reliable estimation of Ambulatory Glucose Profile (AGP) metrics, such as Time in Range (TIR), Time Below Range (TBR), and Time Above Range (TAR). However, the high cost and limited accessibility of CGM restrict its widespread adoption, particularly in low- and middle-income regions. In contrast, self-monitoring of blood glucose (SMBG) is inexpensive and widely available but yields sparse and irregular data that are challenging to translate into clinically meaningful glycemic metrics. In this work, we propose a Dual-Path Attention Neural Network (DPA-Net) to estimate AGP metrics directly from SMBG data. DPA-Net integrates two complementary paths: (1) a spatial-channel attention path that reconstructs a CGM-like trajectory from sparse SMBG observations, and (2) a multi-scale ResNet path that directly predicts AGP metrics. An alignment mechanism between the two paths is introduced to reduce bias and mitigate overfitting. In addition, we develop an active point selector to identify realistic and informative SMBG sampling points that reflect patient behavioral patterns. Experimental results on a large, real-world dataset demonstrate that DPA-Net achieves robust accuracy with low errors while reducing systematic bias. To the best of our knowledge, this is the first supervised machine learning framework for estimating AGP metrics from SMBG data, offering a practical and clinically relevant decision-support tool in settings where CGM is not accessible.